UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Docosahexanoic Acid Plus Vitamin D Treatment Improves Features of NAFLD in Children with Serum Vitamin D Deficiency: Results from a Single Centre Trial

PloS one, 2016-12, Vol.11 (12), p.e0168216-e0168216

2016

Volltextzugriff (PDF)

Medicinal plants and bioactive natural compounds in the treatment of non-alcoholic fatty liver disease: A clinical review

Pharmacological research, 2018-04, Vol.130, p.213-240

2018

Volltextzugriff (PDF)

Gut microbiota profiling of pediatric nonalcoholic fatty liver disease and obese patients unveiled by an integrated meta‐omics‐based approach

Hepatology (Baltimore, Md.), 2017-02, Vol.65 (2), p.451-464

2017

Volltextzugriff (PDF)

Nonalcoholic Fatty Liver Disease in Children

Seminars in liver disease, 2018-02, Vol.38 (1), p.1-13

2018

Volltextzugriff (PDF)

Epidemiology of fatty liver: An update

World journal of gastroenterology : WJG, 2014-07, Vol.20 (27), p.9050-9054

2014

Volltextzugriff (PDF)

Pediatric non alcoholic fatty liver disease: old and new concepts on development, progression, metabolic insight and potential treatment targets

BMC pediatrics, 2013-03, Vol.13 (1), p.40-40, Article 40

2013

Volltextzugriff (PDF)

Statin use and non-alcoholic steatohepatitis in at risk individuals

Journal of hepatology, 2015-09, Vol.63 (3), p.705-712

2015

Volltextzugriff (PDF)

Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease

Hepatology (Baltimore, Md.), 2015-02, Vol.61 (2), p.506-514

2015

Volltextzugriff (PDF)

The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent

Gastroenterology (New York, N.Y. 1943), 2016-05, Vol.150 (5), p.1219-1230.e6

2016

Volltextzugriff (PDF)

The Role of Tissue Macrophage-Mediated Inflammation on NAFLD Pathogenesis and Its Clinical Implications

Mediators of inflammation, 2017, Vol.2017 (2017), p.1-15

2017

Volltextzugriff (PDF)

Gut Microbiota Markers in Obese Adolescent and Adult Patients: Age-Dependent Differential Patterns

Frontiers in microbiology, 2018-06, Vol.9, p.1210-1210

2018

Volltextzugriff (PDF)

I148M patatin‐like phospholipase domain‐containing 3 gene variant and severity of pediatric nonalcoholic fatty liver disease

Hepatology (Baltimore, Md.), 2010-10, Vol.52 (4), p.1274-1280

2010

Volltextzugriff (PDF)

Pediatric nonalcoholic fatty liver disease, metabolic syndrome and cardiovascular risk

World journal of gastroenterology : WJG, 2011-07, Vol.17 (26), p.3082-3091

2011

Volltextzugriff (PDF)

Role of docosahexaenoic acid treatment in improving liver histology in pediatric nonalcoholic fatty liver disease

PloS one, 2014-02, Vol.9 (2), p.e88005-e88005

2014

Volltextzugriff (PDF)

Hepatic progenitor cells activation, fibrosis, and adipokines production in pediatric nonalcoholic fatty liver disease

Hepatology (Baltimore, Md.), 2012-12, Vol.56 (6), p.2142-2153

2012

Volltextzugriff (PDF)

Pediatric non-alcoholic fatty liver disease： Preventive and therapeutic value of lifestyle intervention

World journal of gastroenterology : WJG, 2009-12, Vol.15 (48), p.6017-6022

2009

Volltextzugriff (PDF)

Accuracy and reproducibility of transient elastography for the diagnosis of fibrosis in pediatric nonalcoholic steatohepatitis

Hepatology (Baltimore, Md.), 2008-08, Vol.48 (2), p.442-448

2008

Volltextzugriff (PDF)

Obstructive sleep apnea syndrome affects liver histology and inflammatory cell activation in pediatric nonalcoholic fatty liver disease, regardless of obesity/insulin resistance

American journal of respiratory and critical care medicine, 2014-01, Vol.189 (1), p.66-76

2014

Volltextzugriff (PDF)

The development of the pediatric NAFLD fibrosis score (PNFS) to predict the presence of advanced fibrosis in children with nonalcoholic fatty liver disease

PloS one, 2014-08, Vol.9 (8), p.e104558-e104558

2014

Volltextzugriff (PDF)

Dual role of microRNAs in NAFLD

International Journal of Molecular Sciences, 2013-04, Vol.14 (4), p.8437-8455

2013

Volltextzugriff (PDF)

Non-alcoholic fatty liver disease and metabolic syndrome in adolescents: Pathogenetic role of genetic background and intrauterine environment

Annals of medicine (Helsinki), 2012-02, Vol.44 (1), p.29-40

2012

Volltextzugriff (PDF)

The Liver in Children With Metabolic Syndrome

Frontiers in endocrinology (Lausanne), 2019-08, Vol.10, p.514-514

2019

Volltextzugriff (PDF)

NAFLD in children: A prospective clinical‐pathological study and effect of lifestyle advice

Hepatology (Baltimore, Md.), 2006-08, Vol.44 (2), p.458-465

2006

Volltextzugriff (PDF)

Non-alcoholic fatty liver disease in children now: Lifestyle changes and pharmacologic treatments

Nutrition (Burbank, Los Angeles County, Calif.), 2012-07, Vol.28 (7), p.722-726

2012

Volltextzugriff (PDF)

Performance of ELF Serum Markers in Predicting Fibrosis Stage in Pediatric Non-Alcoholic Fatty Liver Disease

Gastroenterology (New York, N.Y. 1943), 2009, Vol.136 (1), p.160-167

2009

Volltextzugriff (PDF)

1 – 25 von 458

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(424)
Mit Volltextzugriff
(381)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Docosahexanoic Acid Plus Vitamin D Treatment Improves Features of NAFLD in Children with Serum Vitamin D Deficiency: Results from a Single Centre Trial

Medicinal plants and bioactive natural compounds in the treatment of non-alcoholic fatty liver disease: A clinical review

Gut microbiota profiling of pediatric nonalcoholic fatty liver disease and obese patients unveiled by an integrated meta‐omics‐based approach

Nonalcoholic Fatty Liver Disease in Children

Epidemiology of fatty liver: An update

Pediatric non alcoholic fatty liver disease: old and new concepts on development, progression, metabolic insight and potential treatment targets

Statin use and non-alcoholic steatohepatitis in at risk individuals

Transmembrane 6 superfamily member 2 gene variant disentangles nonalcoholic steatohepatitis from cardiovascular disease

The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent

The Role of Tissue Macrophage-Mediated Inflammation on NAFLD Pathogenesis and Its Clinical Implications

Gut Microbiota Markers in Obese Adolescent and Adult Patients: Age-Dependent Differential Patterns

I148M patatin‐like phospholipase domain‐containing 3 gene variant and severity of pediatric nonalcoholic fatty liver disease

Pediatric nonalcoholic fatty liver disease, metabolic syndrome and cardiovascular risk

Role of docosahexaenoic acid treatment in improving liver histology in pediatric nonalcoholic fatty liver disease

Hepatic progenitor cells activation, fibrosis, and adipokines production in pediatric nonalcoholic fatty liver disease

Pediatric non-alcoholic fatty liver disease： Preventive and therapeutic value of lifestyle intervention

Accuracy and reproducibility of transient elastography for the diagnosis of fibrosis in pediatric nonalcoholic steatohepatitis

Obstructive sleep apnea syndrome affects liver histology and inflammatory cell activation in pediatric nonalcoholic fatty liver disease, regardless of obesity/insulin resistance

The development of the pediatric NAFLD fibrosis score (PNFS) to predict the presence of advanced fibrosis in children with nonalcoholic fatty liver disease

Dual role of microRNAs in NAFLD

Non-alcoholic fatty liver disease and metabolic syndrome in adolescents: Pathogenetic role of genetic background and intrauterine environment

The Liver in Children With Metabolic Syndrome

NAFLD in children: A prospective clinical‐pathological study and effect of lifestyle advice

Non-alcoholic fatty liver disease in children now: Lifestyle changes and pharmacologic treatments

Performance of ELF Serum Markers in Predicting Fibrosis Stage in Pediatric Non-Alcoholic Fatty Liver Disease

Suchergebnisse filtern